Does Asthma Phenotype Have Impact on Disease Control (Aperitif)

Bispebjerg Hospital

Status: Completed

Conditions: Asthma

Treatments: Drug: Pulmicort

Study type: Observational

Funder types: Other

Identifiers

NCT01978678

Aperitif

Details and patient eligibility

About

The application of biomarkers that are more closely associated with eosinophillic airway inflammation, such as measurements of FeNO level, cell count in induced sputum or bronchial reactivity could improve asthma control by better directing treatment. A systematic review and meta-analysis is to be conducted to assess the efficacy of tailoring asthma intervention on clinical symptoms compared with exhaled nitric oxide or induced sputum count.

Full description

AHR used as outcome

Enrollment: 80 patients

Sex: All

Ages: 15 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• positiv mannitol
• asthma diagnose

Exclusion criteria

• other lung disease

Trial design

80 participants in 1 patient group

Pulmicort

Description:

ICS and LABA - based on ACQ and FeNO

Treatment:

Drug: Pulmicort